TSLA shares continue to decline after the Q2 2026 earnings disaster, closing at $307.44 on July 28, down 38% from the 52-week high of $498.83. The miss of $0.33 vs $0.535 (-38.3%) and negative free cash flow of -$1.0B shattered near-term credibility. Revenue grew 26% but net income fell 5%, operating margins cratered to 1.4%, and capex doubled to a $25B annual run rate. Product delays for Cybercab, Semi, and Megapack beyond 2026, along with removed Optimus volume language, severely damaged the long-term narrative. The at 18.2 and 10Y yield at 4.6% create a neutral but cautious macro backdrop that penalizes high-duration growth stocks. Technically, the stock is in a free-fall: price well below the 50-day ($385.66) and 200-day ($401.64), histogram accelerating down to -9.65, deeply oversold at 27.0, and in steady decline, confirming institutional distribution. Analyst targets are being slashed (UBS to $385, Morgan Stanley to $400, Truist to $370, Piper Sandler to $450, RBC to $480), and estimates for this year have dropped from $2.13 to $1.79. Insider selling continues with no purchases. The path of least resistance remains lower towards the 52-week low of $297.82. A near-term bounce is possible from oversold levels, but the fundamental thesis is broken and requires a dramatic reversal in execution and capital discipline.
投资判断
实时价格
$307.44
推荐分数
25%
25%
置信度
75%
75%
各期限展望
1个月
卖出
短线
6个月
卖出
中期
1年
卖出
长期
核心催化
Q2 earnings miss and negative free cash flow, combined with product delays, have shattered near-term credibility and will trigger further analyst downgrades and estimate cuts, sustaining downward pressure on the stock.
Avoid or reduce to minimal size (≤10% of normal). The stock is in a technical free-fall with high volatility and negative fundamental catalysts. Shorting is possible but risky given oversold conditions. Only aggressive traders with high risk tolerance should consider a tactical trade with a tight stop.
投资逻辑快照
什么情况涨
Tesla's Q2 delivery beat (480k) and 26% revenue growth prove demand remains strong, and the $27.4B net cash position provides a buffer against the capex cycle. Robotaxi expansion and Optimus progress, though delayed, could still materialize in the next 12-18 months. The market may be overreacting to a single quarter of negative FCF, and the stock could rebound sharply if management delivers on cost cuts and guidance. The deeply oversold of 27 suggests a potential technical bounce.
什么情况跌
The earnings miss was severe and negative free cash flow signals that the capex-heavy strategy is not yet generating returns. Product delays (Cybercab, Semi, Megapack) undermine the entire growth narrative, while operating expenses are out of control. Even after the 38% drop from the high, the forward of ~138x is unjustifiable given deteriorating margins and cash burn. Competition in EVs and robotics is intensifying, and insider selling without purchases indicates management's lack of faith in the near term. Estimate revisions are accelerating downward.
A weekly close above $425 (prior resistance and old mean analyst target area) would invalidate the bearish thesis and suggest the earnings miss was a buying opportunity. Such a move would require a dramatic reversal in sentiment, likely from strong future guidance or a major robotaxi catalyst.
Further earnings estimate downgrades: 0y consensus could drop below $1.50, pushing forward above 200x even at current prices.
Capex overrun and persistent cash burn: If negative FCF continues, the fortress balance sheet could erode within 2-3 years, potentially forcing equity dilution.
Competitive displacement: Waymo in robotaxis and Agility Robotics in humanoid robots are advancing, threatening Tesla's perceived leadership in both domains.
接下来关注
下一次财报：2026年10月21日
Q2 earnings miss and negative free cash flow, combined with product delays, have shattered near-term credibility and will trigger further analyst downgrades and estimate cuts, sustaining downward pressure on the stock.
信号仪表盘
决策输入
6 个信号
基本面
29.9%
距分析师均值目标空间
Even after the 38% decline from the 52-week high, TSLA trades at a forward of ~138x and a ratio of 4.4x, offering no safety margin. FCF yield is a mere 0.4%, and the stock is priced at 11.7x sales. is 111x, exceptionally high for an auto manufacturer. The mean analyst target of $399 is stale and being aggressively lowered; new targets around $370-$480 still leave the stock expensive relative to fading growth and negative free cash flow. Valuation is extreme and vulnerable to further compression.
技术面
Strongly Bearish
趋势质量
Price ($307.44) is well below the 50-day ($385.66) and 200-day ($401.64), with the 50-day below the 200-day (bearish alignment). The stock broke below the June low of $368.6 and is in a confirmed downtrend. No golden cross in sight; the trend is strongly bearish.
财报
84天
Deteriorating
Q2 2026 of $0.33 missed consensus of $0.535 by 38.3%, and negative free cash flow of -$1.0B was a major negative surprise. Revenue beat on delivery strength, but margins and cash flow missed badly.
新闻
Bearish
新闻基调
Q2 earnings miss and negative free cash flow, combined with product delays, have shattered near-term credibility and will trigger further analyst downgrades and estimate cuts, sustaining downward pressure on the stock.
宏观
Neutral
4.60% 10Y / 18.2 VIX
at 18.2 and 10Y at 4.6% create a cautious backdrop; high-beta growth stocks like TSLA are penalized as rising yields compress multiples and the Fed meeting this week adds uncertainty.
稳定性
Speculative / Binary
Tactical Trade
Tesla's business quality is deteriorating rapidly with negative free cash flow, margin compression, and product delays. The stock remains extremely expensive despite the 38% decline from the 52-week high, and insider selling persists. Technical breakdown is severe with price below all key moving averages, and the macro environment is cautious. This is a tactical trade only for aggressive investors; thesis durability is low as execution risk and competition could further erode fundamentals. Drawdown risk is very high due to the extreme volatility and lack of fundamental support.
分析师目标区间
均值目标
$399.45
高低目标
$125 / $600
分析师中值目标
$415.00
共识区间
$125 - $600
— 位分析师
Mean
$125$399$600
市场共识
The analyst community is deeply split: 6 strong buy, 17 buy, 17 hold, 4 sell, 2 strong sell. The mean target of $399 is stale and being cut; the wide high-low range ($125-$600) reflects extreme uncertainty. Post-earnings actions are uniformly negative, with target reductions likely to continue. The distribution leans bearish given the deteriorating fundamentals.
筹码脉冲
内部人信号
Strong Sell
净偏向
Sell-heavy
内部人持股
17.8%
机构持股
43.7%
解读
Persistent discretionary selling by the CFO with no insider purchases indicates weak management confidence, especially ahead of a negative earnings catalyst.
重要活动
CFO Vaibhav Taneja sold $2M and $0.145M about 92-93 days ago. Officer Xiaotong Zhu sold small amounts. No open-market purchases in the past 20 filings.
市场背景
行业
Auto Manufacturers
Mixed-Bullish
情绪
27
跟踪股票
4
分组
industry
Auto Manufacturers 行业 当前情绪为 Mixed-Bullish，板块平均评分约 56 分，资金与评分正在同步走强，且leadership is concentrated in F, RIVN, NIO。
Tesla's robotaxi ambitions are delayed with Cybercab volume production pushed beyond 2026, weakening the near-term monetization narrative. Expansion to new cities continues but pace is slow. The market is reassessing Tesla's ability to generate returns on its massive capex given cash burn and execution risks. The sentiment has turned more negative after the earnings report.
Post-earnings, the focus is on cash burn and product delays, which challenge the robotaxi thesis.
Expansion to new cities provides some progress but pace is insufficient.
Volume production delay contradicts earlier guidance and dents management credibility.
Humanoid Robotics (Optimus)
评分: -75
Bearish
Optimus humanoid robot production is planned but Tesla removed volume production language from its Q2 shareholder letter, signaling delays. The $25B capex commitment is necessary but risky, and returns are years away. Competitors like Agility Robotics are advancing, and Tesla's first-mover advantage is uncertain. Sentiment has shifted from speculative optimism to skepticism.
The earnings report highlighted Optimus supply chain challenges and removed volume language, shifting sentiment from speculative optimism to skepticism.
Tesla ended Model S/X production to make room for Optimus, a major strategic pivot.
Supplier investments indicate long-term commitment, but near-term milestones remain vague.
关键指标
23 项指标
市值
$1.21T
市盈率 (TTM)
284.7
远期市盈率
138.3
营收增速
25.5%
净资产收益率
4.7%
Beta 系数
1.80
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
11.7
市净率
13.7
企业价值 / EBITDA
111.1
质量与资产负债表
利润率、杠杆与流动性。
毛利率
18.9%
营业利润率
1.4%
资产负债率
18.4
流动比率
1.94x
速动比率
1.35x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
2.0%
空头回补天数
1.63x
52周最高
$498.83
52周最低
$297.82
距52周高点
-38.4%
距52周低点
3.2%
公司分类
板块与行业背景。
板块
Consumer Cyclical
行业
Auto Manufacturers
其他信号
自由现金流
$4835999744.00
详细分析
估值
Even after the 38% decline from the 52-week high, TSLA trades at a forward of ~138x and a ratio of 4.4x, offering no safety margin. FCF yield is a mere 0.4%, and the stock is priced at 11.7x sales. is 111x, exceptionally high for an auto manufacturer. The mean analyst target of $399 is stale and being aggressively lowered; new targets around $370-$480 still leave the stock expensive relative to fading growth and negative free cash flow. Valuation is extreme and vulnerable to further compression.
资产负债表
Tesla has a fortress balance sheet: $43.5B cash vs $16.1B debt, net cash of $27.4B (2.3% of market cap). Current ratio of 1.94 and quick ratio of 1.35 are healthy. However, negative free cash flow and capex doubling to a $25B annual run rate are rapidly drawing down cash reserves. If cash burn persists, the balance sheet could weaken within 2-3 years.
增长
Revenue grew 25.5% YoY in Q2, but net income declined 5% YoY, and earnings growth is negative. Margins are compressing: gross margin 18.9%, operating margin 1.4%, margin 10.4%. The growth narrative depends on robotaxi and Optimus monetization, but both face significant delays. Growth is decelerating and increasingly capital-intensive.
生意质量
Gross margin at 18.9%, operating margin at 1.4%, and margin at 10.4% are weak for a company with a market cap over $1.2T. is 4.7% and is 1.9%, well below levels justifying a premium valuation. The business is cyclical, capital-intensive, and faces margin pressure from competition and heavy investment. Business quality does not support the current multiple.
资本配置
Management is investing aggressively in AI and production capacity ($25B capex in 2026), leading to negative free cash flow. No share buybacks are in place. While the cash pile provides flexibility, the capital allocation strategy is high-risk and prioritizes long-term bets over near-term profitability, which could erode shareholder value if returns fail to materialize.
预期修正
estimates are collapsing post-earnings. The 0-year consensus fell from $2.13 (7 days ago) to $1.79, a 16% decline. +1-year estimates dropped from $2.55 to $2.22. Analyst actions are uniformly negative with multiple target reductions (UBS to $385, Morgan Stanley to $400, Truist to $370, Piper Sandler to $450, RBC to $480). The revision signal is sharply bearish and could accelerate further.